10x Genomics Dips After Thermo Fisher's Weak Numbers

10x Genomics stocks plummeted over six percent following Thermo Fishers disappointing quarterly results, with organic growth at just one percent, far below expectations. Investors concerns about slowing demand in lab gear industry led to a sell-off, dragging 10x Genomics down. Despite todays drop, 10x Genomics is still up twenty-nine percent this year and a one-thousand-dollar investment from five years ago would now be worth around one hundred ten dollars. This dip may be a market overreaction, leaving room for 10x Genomics to recover if the industry stabilizes. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8fb0e26a1cb73a22